Learn More
Medchemexpress LLC 8-(4-(trifluoromethyl)phenyl)-N-(1,1,1-trifluoropropan-2-yl)-dihydro-naphthyridine-7-carboxamide | 1470018-52-0 | 99.9% | 417.35 g/mol | C19H17F6N3O | 5 MG

Supplier: Medchemexpress LLC HY1040595MG
AMG2850 is a potent, orally bioavailable, and selective antagonist of the TRPM8 ion channel developed for preclinical research. It blocks menthol- and cold-induced TRPM8 activation in cellular assays and has been characterized in pharmacology studies assessing sensory signaling and pain mechanisms. Supplied as a solid research chemical for laboratory use only.
- Potent, selective TRPM8 antagonist.
- Orally bioavailable in preclinical models.
- Inhibits menthol- and cold-induced TRPM8 activation in vitro.
- Supplied as a solid with high purity suitable for research.
- Useful for studies of sensory signaling and pain mechanisms.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.